“biomerieux” Archives

Entry Author Date Location
Bought By Utah Rival Tute, Former Genomics High Flyer Knome Bows Out 11/02/15 Boston
T2 Biosystems Sputters Through IPO Queue, Raises $57M 08/07/14 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
NeuroPhage Pharmaceuticals Secures $6,400,000 New Funding Round 05/06/13 Boston
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug” 12/06/12 Boston
Celgene Pumps Up Acceleron, On-Q-ity CEO Goes to Roche Unit, MSMB Eyes Amag, & More Boston-Area Life Sciences News 08/05/11 Boston
Stéphane Bancel, Former bioMérieux CEO, Talks Future of Startups, Diagnostics, Pharma 08/04/11 Boston
NeuroPhage Pharmaceuticals Garners $12,400,000 Series B Financing 03/01/11 Boston
Warner Bros. Acquires Turbine, Athenahealth Taps IBM, Alkermes Reveals Diabetes Drug Royalty, & More Boston-Area Deals News 04/28/10 Boston
Genzyme Expects to Pay $175M to FDA, Westphal Leaves Sirtris to Run GSK Venture Arm, Gelesis Obesity Treatment Passes First Human Trial, & More Boston-Area Life Sciences News 04/23/10 Boston
Knome Gets $5M From bioMérieux 04/21/10 Boston
Knome Receives $5,000,000 New Funding 04/21/10 Boston
San Diego’s BioTheranostics Gears Up to Sell Test That Predicts Breast Cancer Relapse 12/12/09 San Diego
Page 1 of 1